HS Code:
The category of Cocaine, ecgonine; salts, esters, and other derivatives thereof falls under HS Code 2939.91. This category includes cocaine, a powerful stimulant drug derived from coca leaves, as well as ecgonine, a tropane alkaloid and precursor to cocaine, and their related salts, esters, and derivatives. Due to its psychoactive properties and high potential for abuse, this category is heavily regulated under international drug control treaties such as the United Nations Single Convention on Narcotic Drugs of 1961. Trade in these substances is generally restricted to medical and scientific purposes under strict licensing and monitoring. Global trade data for this category is limited and often not publicly disclosed due to legal and ethical concerns.
Total Trade Volume
Data not publicly available due to regulatory restrictions
Data from 2023
Source
United Nations Office on Drugs and Crime (UNODC), International Narcotics Control Board (INCB)
Average Rate
Not applicable due to controlled status; tariffs are secondary to regulatory bans
Highest Rate
Not applicable
Lowest Rate
Not applicable
Increased international cooperation on drug control
Stricter monitoring and reduced legal trade; focus on curbing illicit trafficking
2020-2023
Rise in synthetic alternatives and analogs
Shift in illicit markets to non-traditional derivatives, complicating regulation
2021-2023
Limited legal production for medical research
Minimal trade under tightly controlled conditions for pharmaceutical research
2019-2023
The International Narcotics Control Board updated guidelines to enhance tracking of controlled substances like cocaine and its derivatives for medical use, aiming to prevent diversion to illicit markets.
March 2023
Further restriction on legal trade channels; increased reporting burden on countries
The UNODC released a report highlighting a surge in illicit cocaine production and trafficking, particularly from South America, despite global control measures.
June 2023
Increased focus on border controls and international law enforcement collaboration
Some countries have adjusted licensing frameworks to allow limited research on cocaine derivatives for potential therapeutic uses, under strict oversight.
October 2022
Slight increase in legal trade for research purposes, though still negligible in volume